United States of America
Dr. Ronald Herbst is Vice President of Research and Development and Head of Oncology Research for MedImmune. In this role, Ronald is responsible for the overall oncology research strategy and pre-clinical development of novel drug candidates. Ronald joined MedImmune in February, 2006 as associate director of oncology research. Prior to MedImmune Ronald was Senior Principal Investigator in the Oncology Department at Schering-Plough Biopharma (formerly DNAX).
His research interest in Business and Management